| scholarly article | Q13442814 |
| P50 | author | Yuhang Ai | Q88255297 |
| P2093 | author name string | Allan Tsung | |
| Lemeng Zhang | |||
| P2860 | cites work | Autophagy in idiopathic pulmonary fibrosis | Q21134133 |
| Network organization of the human autophagy system | Q24324004 | ||
| Autophagy in immunity and inflammation | Q24595707 | ||
| Severe sepsis and septic shock | Q27026614 | ||
| Autophagy in the Pathogenesis of Disease | Q27860558 | ||
| Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care | Q27860820 | ||
| Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy | Q28131727 | ||
| A role for mitochondria in NLRP3 inflammasome activation | Q28131794 | ||
| Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death | Q28240733 | ||
| Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases | Q28263484 | ||
| Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis | Q28483646 | ||
| Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis | Q28585138 | ||
| Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β | Q29030555 | ||
| Regulation mechanisms and signaling pathways of autophagy | Q29547416 | ||
| Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome | Q29547419 | ||
| The biochemistry of apoptosis | Q29547741 | ||
| Circulating mitochondrial DAMPs cause inflammatory responses to injury | Q29614470 | ||
| mTOR regulation of autophagy | Q29616301 | ||
| Autophagy in cell death: an innocent convict? | Q29617604 | ||
| Self-eating and self-killing: crosstalk between autophagy and apoptosis | Q29617748 | ||
| The pathophysiology and treatment of sepsis | Q29619103 | ||
| Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. | Q30491528 | ||
| Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease | Q33373335 | ||
| When apoptosis meets autophagy: deciding cell fate after trauma and sepsis | Q33622935 | ||
| Fall in circulating mononuclear cell mitochondrial DNA content in human sepsis | Q33666825 | ||
| Kinetics and protective role of autophagy in a mouse cecal ligation and puncture-induced sepsis | Q33751153 | ||
| Biochemical pathways of caspase activation during apoptosis | Q33804316 | ||
| Atg7 deficiency impairs host defense against Klebsiella pneumoniae by impacting bacterial clearance, survival and inflammatory responses in mice | Q34131740 | ||
| Autophagy protein microtubule-associated protein 1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smoke-induced emphysema | Q34279364 | ||
| In vivo requirement for Atg5 in antigen presentation by dendritic cells | Q34376166 | ||
| Discovery of Atg5/Atg7-independent alternative macroautophagy | Q34612369 | ||
| Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertension | Q34840778 | ||
| Augmenting autophagy to treat acute kidney injury during endotoxemia in mice | Q34920346 | ||
| Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis | Q35144095 | ||
| In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice | Q35848213 | ||
| Interferon regulatory factor-1 regulates the autophagic response in LPS-stimulated macrophages through nitric oxide | Q35872539 | ||
| Splenocyte apoptosis and autophagy is mediated by interferon regulatory factor 1 during murine endotoxemia | Q35894838 | ||
| Immunosuppression in patients who die of sepsis and multiple organ failure | Q35991015 | ||
| Leukocyte apoptosis and its significance in sepsis and shock | Q36092243 | ||
| A critical role for the autophagy gene Atg5 in T cell survival and proliferation | Q36228924 | ||
| MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis | Q36229458 | ||
| The emerging importance of autophagy in pulmonary diseases | Q36388052 | ||
| Differential efficacy of caspase inhibitors on apoptosis markers during sepsis in rats and implication for fractional inhibition requirements for therapeutics | Q36399039 | ||
| BCL2 family in DNA damage and cell cycle control | Q36501194 | ||
| Apoptosis and caspases regulate death and inflammation in sepsis | Q36622618 | ||
| Promising therapeutic agents for sepsis | Q36659737 | ||
| Prevention of lymphocyte cell death in sepsis improves survival in mice | Q36748242 | ||
| The apoptotic pathway as a therapeutic target in sepsis | Q36789484 | ||
| The pathogenesis of sepsis. | Q36934401 | ||
| Regulatory T cell populations in sepsis and trauma. | Q36959555 | ||
| MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. | Q36981000 | ||
| Secretory versus degradative autophagy: unconventional secretion of inflammatory mediators | Q37046163 | ||
| Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling | Q37115242 | ||
| Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival. | Q37142173 | ||
| Antimicrobial autophagy: a conserved innate immune response in Drosophila | Q37238107 | ||
| Prevention of immune cell apoptosis as potential therapeutic strategy for severe infections | Q37302645 | ||
| Modulation of the Bcl-2 family blocks sepsis-induced depletion of dendritic cells and macrophages. | Q37422786 | ||
| The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer? | Q37563023 | ||
| Regulation of autophagy in mammals and its interplay with apoptosis. | Q37694356 | ||
| The role of autophagy in cancer: therapeutic implications | Q37924056 | ||
| Life in the balance - a mechanistic view of the crosstalk between autophagy and apoptosis | Q38078813 | ||
| The mechanism and physiological function of macroautophagy. | Q38115111 | ||
| Intrinsic and extrinsic mechanisms of dendritic morphogenesis | Q38267076 | ||
| Emerging role of selective autophagy in human diseases | Q38270177 | ||
| Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. | Q38483410 | ||
| mTOR inhibitors radiosensitize PTEN-deficient non-small-cell lung cancer cells harboring an EGFR activating mutation by inducing autophagy | Q39165050 | ||
| The decline of autophagy contributes to proximal tubular dysfunction during sepsis | Q39442083 | ||
| The redox protein HMGB1 regulates cell death and survival in cancer treatment | Q39652611 | ||
| Autophagy gene-dependent clearance of apoptotic cells during embryonic development | Q40160979 | ||
| The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death | Q40403905 | ||
| Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration | Q40543299 | ||
| Mitophagy plays an essential role in reducing mitochondrial production of reactive oxygen species and mutation of mitochondrial DNA by maintaining mitochondrial quantity and quality in yeast | Q40810283 | ||
| Proteolytic activities that mediate apoptosis | Q41748380 | ||
| Targeted delivery of siRNA to cell death proteins in sepsis. | Q41768037 | ||
| Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity | Q44569265 | ||
| Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte | Q45018156 | ||
| Enhancing autophagy with activated protein C and rapamycin protects against sepsis-induced acute lung injury | Q45082321 | ||
| Autophagy is essential for mitochondrial clearance in mature T lymphocytes | Q45162920 | ||
| Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice | Q45792621 | ||
| Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group | Q46886444 | ||
| Lc3 over-expression improves survival and attenuates lung injury through increasing autophagosomal clearance in septic mice. | Q50490888 | ||
| Loss of Dictyostelium ATG9 results in a pleiotropic phenotype affecting growth, development, phagocytosis and clearance and replication of Legionella pneumophila. | Q51918047 | ||
| Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. | Q53597468 | ||
| Enhanced dendritic cell survival attenuates lipopolysaccharide-induced immunosuppression and increases resistance to lethal endotoxic shock. | Q54534377 | ||
| Compensatory anti-inflammatory response syndrome | Q56270656 | ||
| Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction | Q57773627 | ||
| Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group | Q71094855 | ||
| Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial | Q72285461 | ||
| Sepsis induces apoptosis and profound depletion of splenic interdigitating and follicular dendritic cells | Q73627319 | ||
| Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans | Q73896312 | ||
| Depletion of dendritic cells, but not macrophages, in patients with sepsis | Q77671545 | ||
| The autophagy gene ATG5 plays an essential role in B lymphocyte development | Q80477595 | ||
| Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure | Q81482696 | ||
| Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways | Q81621957 | ||
| Complete induction of autophagy is essential for cardioprotection in sepsis | Q83632554 | ||
| P433 | issue | 4 | |
| P921 | main subject | autophagy | Q288322 |
| sepsis | Q183134 | ||
| P304 | page(s) | 1159-1167 | |
| P577 | publication date | 2016-02-11 | |
| P1433 | published in | Experimental and Therapeutic Medicine | Q23979083 |
| P1476 | title | Clinical application: Restoration of immune homeostasis by autophagy as a potential therapeutic target in sepsis | |
| P478 | volume | 11 |
| Q47141795 | Activation of autophagy is involved in the protective effect of 17β-oestradiol on endotoxaemia-induced multiple organ dysfunction in ovariectomized rats. |
| Q55364694 | Downregulated Tim-3 expression is responsible for the incidence and development of colorectal cancer. |
| Q60303389 | Inflammasomes: Pandora's box for sepsis |
| Q64947698 | Targeting ATG4 in Cancer Therapy. |
| Q57787314 | The Relationship Between Sepsis-induced Immunosuppression and Serum Toll-like Receptor 9 Level |
| Q90050019 | The Role of Autophagy in Sepsis: Protection and Injury to Organs |
Search more.